Analysis of the molecular heterogeneity of the microtubule-associated protein tau by two-dimensional electrophoresis and RT-PCR

Brain Research Protocols

Volumn 5, Issue 3, 2000, Pages 231-242

  Janke, Carsten ^a   Beck, Mike ^a   Holzer, Max ^a   Bigl, Volker ^a   Arendt, Thomas ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Dementia; Isoform; mRNA splicing; Phosphorylation; Tau protein; Two dimensional gel electrophoresis

Indexed keywords

TAU PROTEIN;

AGAR GEL ELECTROPHORESIS; ALZHEIMER DISEASE; ANIMAL TISSUE; ARTICLE; CHROMOSOME 17; CONTROLLED STUDY; FRONTOTEMPORAL DEMENTIA; GENETIC LINKAGE; HUMAN; HUMAN TISSUE; MICROTUBULE; MOLECULAR GENETICS; NONHUMAN; PHOSPHORYLATION; PICK PRESENILE DEMENTIA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SPLICING;

ANIMALS; BASE SEQUENCE; BLOTTING, WESTERN; DEMENTIA; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; GENETIC HETEROGENEITY; HUMANS; MOLECULAR SEQUENCE DATA; PHOSPHORYLATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA SPLICING; RNA, MESSENGER; TAU PROTEINS;

EID: 0033947241     PISSN: 1385299X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1385-299X(00)00018-0     Document Type: Article

References (44)

1. Anderson N.L., Anderson N.G. Proteome and proteomics: new technologies, new concepts, and new words. Electrophoresis. 19:1998;1853-1861.
2. Ausubel F.A., Brent R., Kingston R.E., Moore D.D., Seidman J.G., Smith J.A., Struhl K. Current Protocols in Molecular Biology. 1996;Wiley, New York.
3. Biernat J., Mandelkow E.M., Schroter C., Lichtenberg-Kraag B., Steiner B., Berling B., Meyer H., Mercken M., Vandermeeren A., Goedert M., et al. The switch of tau protein to an Alzheimer-like state includes the phosphorylation of two serine-proline motifs upstream of the microtubule binding region. EMBO J. 11:1992;1593-1597.
4. Bjerrum O.J., Schafer-Nielsen C. Dunn M.J. Analytical Electrophoresis. 1986;315 Verlag Chemie, Weinheim.
5. Blackstock W.P., Weir M.P. Proteomics: quantitative and physical mapping of cellular proteins. Trends Biotechnol. 17:1999;121-127.
6. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
7. Butler M., Shelanski M.L. Microheterogeneity of microtubule-associated tau proteins is due to differences in phosphorylation. J. Neurochem. 5:1986;1517-1522.
8. Celis J.E., Ostergaard M., Jensen N.A., Gromova I., Rasmussen H.H., Gromov P. Human and mouse proteomic databases: novel resources in the protein universe. FEBS Lett. 430:1998;64-72.
9. Chen W.T., Liu W.K., Yen S.H. Expression of tau exon 8 in different species. Neurosci. Lett. 172:1994;167-170.
10. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
11. Cleveland D.W., Hwo S.Y., Kirschner M.W. Physical and chemical properties of purified tau factor and the role of tau in microtubule assembly. J. Mol. Biol. 116:1977;227-247.
12. Couchie D., Mavilia C., Georgieff I.S., Liem R.K., Shelanski M.L., Nunez J. Primary structure of high molecular weight tau present in the peripheral nervous system. Proc. Natl. Acad. Sci. USA. 89:1992;4378-4381.
13. Gärtner U., Janke C., Holzer M., Vanmechelen E., Arendt T. Post-mortem changes in the phosphorylation state of tau protein in rat brain. Neurobiol. Aging. 19:1998;535-543.
14. Georgieff I.S., Liem R.K., Couchie D., Mavilia C., Nunez J., Shelanski M.L. Expression of high molecular weight tau in the central and peripheral nervous systems. J. Cell Sci. 105:1993;729-737.
15. Georgieff I.S., Liem R.K., Mellado W., Nunez J., Shelanski M.L. High molecular weight tau: preferential localization in the peripheral nervous system. J. Cell Sci. 100:1991;55-60.
16. Gilliland G., Perrin S., Blanchard K., Bunn H.F. Analysis of cytokine mRNA and DNA: Detection and quantitation by competitive polymerase chain reaction. Proc. Natl. Acad. Sci. USA. 87:1990;2725-2729.
17. Goedert M., Crowther R.A., Garner C.C. Molecular characterization of microtubule-associated proteins tau and MAP2. Trends Neurosci. 14:1991;193-199.
18. Goedert M., Jakes R. Expression of separate isoforms of human tau protein: correlation with the tau pattern in brain and effects on tubulin polymerization. EMBO J. 9:1990;4225-4230.
19. Goedert M., Jakes R., Crowther R.A. Effects of frontotemporal dementia FTDP-17 mutations on heparin-induced assembly of tau filaments. FEBS Lett. 450:1999;306-311.
20. Goedert M., Spillantini M.G., Jakes R., Rutherford D., Crowther R.A. Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease. Neuron. 3:1989;519-526.
21. Goedert M., Spillantini M.G., Potier M.C., Ulrich J., Crowther R.A. Cloning and sequencing of the cDNA encoding an isoform of microtubule-associated protein tau containing four tandem repeats: differential expression of tau protein mRNAs in human brain. EMBO J. 8:1989;393-399.
22. Goode B.L., Denis P.E., Panda D., Radeke M.J., Miller H.P., Wilson L., Feinstein S.C. Functional interactions between the proline-rich and repeat regions of tau enhance microtubule binding and assembly. Mol. Biol. Cell. 8:1997;353-365.
23. Goode B.L., Feinstein S.C. Identification of a novel microtubule binding and assembly domain in the developmentally regulated inter-repeat region of tau. J. Cell Biol. 124:1994;769-782.
24. Greenberg S.G., Davies P., Schein J.D., Binder L.I. Hydrofluoric acid-treated PHF-tau proteins display the same biochemical properties as normal tau. J. Biol. Chem. 267:1992;564-569.
25. Grover A., Houlden H., Baker M., Adamson J., Lewis J., Prihar G., Pickering-Brown S., Duff K., Hutton M. 5′ splice site mutations in tau associated with the inherited dementia FTDP-17 affect a stem-loop structure that regulates alternative splicing of exon 10. J. Biol. Chem. 274:1999;15134-15143.
26. Hagestedt T., Lichtenberg B., Wille H., Mandelkow E.M., Mandelkow E. Tau protein becomes long and stiff upon phosphorylation: Correlation between paracrystalline structure and degree of phosphorylation. J. Cell Biol. 109:1989;1643-1651.
27. Hong M., Zhukareva V., Vogelsberg-Ragaglia V., Wszolek Z., Reed L., Miller B.I., Geschwind D.H., Bird T.D., McKeel D., Goate A., Morris J.C., Wilhelmsen K.C., Schellenberg G.D., Trojanowski J.Q., Lee V.M. Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17. Science. 282:1998;1914-1917.
28. Hochstrasser D.F. Proteome in perspective. Clin. Chem. Lab. Med. 36:1998;825-836.
29. Hutton M., Lendon C.L., Rizzu P., Baker M., Froelich S., Houlden H., Pickering-Brown S., Chakraverty S., Isaacs A., Grover A., Hackett J., Adamson J., Lincoln S., Dickson D., Davies P., Petersen R.C., Stevens M., de Graaff E., Wauters E., van Baren J., Hillebrand M., Joosse M., Kwon J.M., Nowotny P., Kuei Che L., Norton J., Morris J.C., Reed L.A., Trojanowski J., Basum H., Lannfelt L., Neystat M., Fahn S., Dark F., Tannenberg T., Dood P.R., Hayward N., Kwok J.B.J., Schofield P.R., Andreadis A., Snowden J., Craufurd D., Neary D., Owen F., Oostra B.A., Hardy J., Goate A., van Swieten J., Mann D., Lynch T., Heutink P. Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17. Nature. 393:1998;702-705.
30. Janke C., Beck M., Stahl T., Holzer M., Brauer K., Bigl V., Arendt T. Phylogenetic diversity of the expression of the microtubule-associated protein tau: Implications for neurodegenerative disorders. Mol. Brain Res. 68:1999;119-128.
31. Janke C., Holzer M., Klose J., Arendt T. Distribution of isoforms of the microtubule-associated protein tau in grey and white matter areas of human brain: a two-dimensional gel electrophoretic analysis. FEBS Lett. 379:1996;222-226.
32. Kosik K.S., Orecchio L.D., Bakalis S., Neve R.L. Developmentally regulated expression of specific tau sequences. Neuron. 2:1989;1389-1397.
33. Ksiezak-Reding H., Davies P., Yen S.-H. Alz 50, a monoclonal antibody to Alzheimer's disease antigen, cross-reacts with tau proteins from bovine and normal human brain. J. Biol. Chem. 17:1988;7943-7947.
34. Ksiezak-Reding H., Binder L.I., Yen S.-H. Immunochemical and biochemical characterization of tau proteins in normal and Alzheimer's disease brain with Alz-50 and Tau-1. J. Biol. Chem. 17:1988;7948-7953.
35. Laemmli U.K. Cleavage of structural proteins during the assembly of bacteriophage T4. Nature. 227:1970;680-685.
36. Litersky J.M., Johnson G.V. Phosphorylation by cAMP-dependent protein kinase inhibits the degradation of tau by calpain. J. Biol. Chem. 267:1992;1563-1568.
37. Litersky J.M., Scott C.W., Johnson G.V. Phosphorylation, calpain proteolysis and tubulin binding of recombinant human tau isoforms. Brain Res. 604:1993;32-40.
38. Mavilia C., Couchie D., Nunez J. Diversity of high-molecular-weight tau proteins in different regions of the nervous system. J. Neurochem. 63:1994;2300-2306.
39. O'Farrell P.Z., Goodman H.M., O'Farrell P.H. High resolution two-dimensional electrophoresis of basic as well as acidic proteins. Cell. 12:1977;1133-1142.
40. Scott C.W., Blowers D.P., Barth P.T., Lo M.M.S., Salama A.I., Caputo C.B. Differences in the abilities of human tau isoforms to promote microtubule assembly. J. Neurosci. Res. 30:1991;154-162.
41. Spillantini M.G., Murrell J.R., Goedert M., Farlow M.R., Klug A., Ghetti B. Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. Proc. Natl. Acad. Sci. USA. 95:1998;7737-7741.
42. Szendrei G.I., Lee V.M., Otvos L. Jr. Recognition of the minimal epitope of monoclonal antibody Tau-1 depends upon the presence of a phosphate group but not its location. J. Neurosci. Res. 34:1993;243-249.
43. Tranchant C., Sergeant N., Wattez A., Mohr M., Warter J.M., Delacourte A. Neurofibrillary tangles in Gerstmann-Straussler-Scheinker syndrome with the A117V prion gene mutation. J. Neurol. Neurosurg. Psychiatry. 63:1997;240-246.
44. Zor T., Selinger Z. Linearisation of the Bradford protein assay increases its sensitivity: Theoretical and experimental studies. Anal. Biochem. 236:1996;302-308.